RecruitingNCT06232395

Early Detection and Post-operative Monitoring of Gastric Cancer

Early Detection and Post-operative Monitoring of Gastric Cancer Using Circulating DNA in Blood Samples

Sponsor

Suzhou Huhu Health & Technology Inc.

Enrollment

1,197 participants

Start Date

Feb 18, 2024

Study Type

OBSERVATIONAL

Conditions

Gastric Cancer

Summary

This study is to determine the performance of non-invasive new multi-target biomarkers in the early detection and post-operative monitoring of gastric cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Subject age over 18.
Subject has stomach discomfort, and seek medical attention at the Gastric Surgery Department of our center.
Subject has or will have gastroscopy and/or pathological examination results at this center.
Subject must be able to fully understand the informed consent form and be able to personally sign it.

Exclusion Criteria6

Subject has serious heart, liver, kidney dysfunction, or mental illness.
Subject diagnosed previously with any kind of malignant tumor.
Subject is known to be infected with HIV or other related diseases (considering interference from the use of immune drugs).
Subject is receiving targeted drugs, immunosuppressants, immunomodulators, and biological therapies.
Researchers believe that subject is not suitable for enrollment.
Subject can not supply sufficient sample to complete this experiment.